NanoPass Technologies
Latest round
- Series B
Last raised
- Jul 2012
Total raised
- $6.5M
Investors
- 3
About NanoPass Technologies
NanoPass Technologies Ltd is an innovative company dedicated to developing intradermal delivery systems. Founded in 2000 in Israel by Shuki Yeshurun, the company has undergone strategic developments in its operations, particularly with its focus on advanced delivery systems.NanoPass Technologies specializes in advanced intradermal delivery solutions, with a focus on the MicronJet™ product platform. This flagship offering utilizes Micro Electro Mechanical Systems (MEMS) technology to create a distinctive hollow pyramid design, enabling precise, safe, and efficient delivery of vaccines and drugs through the skin.6mm MicronJet™ is notable for being the smallest intradermal delivery device to receive FDA clearance. The company's products primarily address the need for pain-free delivery methods in therapeutic and aesthetic medical applications, targeting healthcare providers and pharmaceutical companies as key clients.NanoPass generates revenue through B2B transactions with pharmaceutical companies, healthcare providers, and distributors. The company’s revenue model is structured around the direct sale of its MicronJet™ devices, which are adopted for clinical use in various therapeutic and vaccine delivery applications. Pricing is aligned with the value proposition of providing virtually pain-free delivery solutions tailored to the needs of institutional buyers.The company is focused on expanding its product offerings and global market reach. Future products are expected to include enhanced versions of the MicronJet™ technology, with planned launches in the next 12 to 18 months.00 mn to support these initiatives.
Who invested in NanoPass Technologies
3 investors across 2 rounds
See all investors in NanoPass Technologies
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about NanoPass Technologies
Who invested in NanoPass Technologies?
NanoPass Technologies has 3 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has NanoPass Technologies raised?
NanoPass Technologies has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did NanoPass Technologies last raise money?
NanoPass Technologies's most recent round on record is a Series B, in Jul 2012.
What does NanoPass Technologies do?
NanoPass Technologies Ltd is an innovative company dedicated to developing intradermal delivery systems.
Where is NanoPass Technologies headquartered?
NanoPass Technologies is headquartered in Israel.
Which VCs invest in companies like NanoPass Technologies?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back biotechnology companies at NanoPass Technologies's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like NanoPass Technologies? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.